Some of these genes (such as the BTG2 gene, MYD88 gene and IL-25 genes) have been found to be closely related to the progression, chemotherapy resistance and inferior OS of lymphoma, and some have become potential therapeutic targets [28, 29, 48]. This evidence concerns the gene IL25 and lymphoma.